Introduction
Symptomatic chronic subdural hematomas (SCSH) are common in neurosurgical practice. They are found primarily in the elderly (1, 2) . Clinical history generally includes mild to moderate head trauma (2, 8) . Other main risk factors comprise alcohol abuse, cephalospinal fluid shunts, antiplatelet agents, coagulopathies, and therapeutic anticoagulation (2, 15, 33) . For asymptomatic chronic subdural hematomas, treatment options reported in the literature include conservative neurological surveillance combined with bed rest and corticosteroid therapy (27) . Surgery is generally recommended when chronic subdural hematomas become symptomatic. The optimal surgical procedure, the use of a closeddrainage system, and modalities of post-operative management are under ongoing debate (1, 3, 9, 12, 14, 25, 34, 37) . Complications of surgery mainly include infection, acute hemorrhage, post-operative seizure, symptomatic hygroma, and symptomatic pneumocephalus (16, 22, 29) .
Surgical methods proposed in recent literature mainly include twist-drill craniostomy, burr-hole trepanation, and multiple variants of craniotomy (10, 17, 21, 23, 31, 36) . At present, burr-hole surgery with subdural closed-drainage system is the most commonly chosen strategy. This technique was repeatedly shown to be effective and safe (7, 8, 14, 18, 20, 22, 23, 32, 34, 36, 37) . More recently, enlarged single-burr-hole trepanation in combination with a suction-assisted subgaleal draining system has also earned consideration as a safe and effective approach (7) .
In the present article, we analyze our 5-year experience with two-burr-hole trepanation combined with a subperiostal, i.e. extracranial, non-aspiring draining system. We argue about the importance and modalities of post-operative medical management. By comparing our series to alternate techniques published so far, we illustrate the effectiveness and safety of the technique where there is no contact of the drain with the fragile subdural membranes, brain surface or bridging veins as it is inserted in a subperiostal fashion.
Patients and Methods

General features:
We retrospectively reviewed data of all consecutive patients who underwent surgery for SCSH in the Centre Hospitalier Universitaire Vaudois (CHUV) between January 2002 and January 2007. General patient information was collected, including patients' age, sex, and specific risk factors. The pre-operative Glasgow Coma Scale (GCS) score, and relevant neurological findings were noted. The main clinical finding that motivated subsequent surgery was also determined. CT scan protocols were reviewed regarding the side of the hematoma, and whether the hematoma was uni-or bilateral. Surgery protocols were inspected regarding the side of trepanation, and whether the trepanation was uni-or bilateral. All peri-operative complications were further investigated. In case of post-operative infection, we differentiated between superficial, thus extracranial infections, and deep, subdural or intraparenchymal infection. Detection of hematoma recurrence was based on a daily neurological examination, and subsequently confirmed by CT scanning. In those cases where hematoma persistence or recurrence was identified, we determined the type of second intention treatment applied.
Hospitalization protocols were examined regarding the duration of hospitalization and the patient orientation at discharge. Finally, outcome was evaluated on the basis of a routine clinical assessment 3 months after surgery that included determination of the Glasgow Outcome Scale (GOS) score (11) .
Clinical management:
A standard treatment protocol was applied to all cases. Pre-operative management included medical normalization of the coagulation parameters, and platelet substitution in the presence of antiplatelet drugs. Surgery was generally performed under general anesthesia. 
Results
General features:
A total of 147 consecutive adult patients with a mean age of 71.5 years (range 42 to 93 years) and a male predominance of 76.9 % were found in our operative database and included in the present study. Thirty-six (24.5%) of these patients presented with bilateral SCSH. A total of 183 hemispheres were thus trepanated. History taking revealed past mild or moderate head trauma in 117 patients (79.6 %). Other risk factors included oral anticoagulation or anticoagulating disease in 27.9 %, taking of antiplatelet drugs in 25.1 %, and chronic alcohol abuse in 12.2 %. The indication for surgery was mainly based on the discovery of progressive neurological deficits. Findings included unilateral weakness in 61.9 %, acute state of confusion in 10.8 %, and decreasing level of consciousness in 8.2 %. Other indications for surgery included harsh headache in 6.8 %, imbalance resulting in spontaneous falls in 4.8 %, inaugural seizure in 2.7 %, diffuse neuropsychological findings in 2 %, and aphasic disorders in 1.4 %. Details are given in Table 1 .
Surgical procedure:
Unilateral two-burr-hole trepanation was performed in a total of 111 cases (75.5 %), from which 71 (48.3%) were left-sided, and 40 (27.2%) were right-side-only procedures.
Bilateral trepanation in one session was done in the remaining 36 cases (24.5 %) ( Table 2) .
Outcome:
The GOS score at 3 months follow-up was 5 in 108 patients (73.5%), 4 in 28 patients (19%), 3 in 5 patients (3.4%), 2 in 1 patient (0.7%) and 1 in 5 patients (3.4%). The mean duration of hospitalization was 8.8 days (range 3 to 36 days). Patients were discharged without particular ongoing medical measures in 48.3 %, and 15.6% were referred to a rehabilitation clinic for reason of persistent neurological deficits. The remaining 32.7 % were transferred to the referring hospital for non-neurosurgical medical investigations and therapy.
Hematoma persistence or recurrence confirmed by CT scans occurred in 22 patients (15%) or 24 operated sides (13.1%). Recurrence was defined as the reappearance of relevant neurological deficits. Second intention procedure was performed in 17 patients (11.6%). This comprised re-trepanation in 15 patients (10.2%) and craniotomy in 2 patients (1.4 %). Second intention trepanation was applied to all cases with documented symptomatic recurrence. All patients with documented but asymptomatic persistence (3.4 %) underwent conservative therapy.
Complications:
The overall complication rate was 10.9 % per operated side. The intraoperative mortality was 0.7 %, and the perioperative mortality was 3.4 %. Of the 5 patients who expired during hospitalization, two patients continued to bleed acutely from subdural membranes despite trepanation. The decision to stay away from a second intervention was taken on the basis of the patients' general health condition and the patients' age. One patient with severe coagulopathy developed post-operative epidural bleeding and expired despite craniotomy.
One patient developed cardiac arrest during surgery, but before trepanation could be done. He finally expired from therapy-refractory pulmonary failure. One patient developed severe atelectasy in the post-operative phase and expired from cardio-pulmonary failure despite intensive respiratory therapy.
Infection occurred in 3 patients (2 %) and 1.6% of the operated sides. Two patients 
Discussion
Treatment of SCSH should be effective, safe, technically easy, and cost-efficient. Most surgical strategies include the use of a draining system with the catheter tip inserted into the subdural space. The aim of this practice is to allow brain re-expansion through progressive evacuation of rinsing fluid and residual subdural blood. In the present series, the drain was inserted epicranially under the periosteum leaving the draining holes over both burr-holes (Figure) . In accordance with Gazzeri et al. (7), the extracranial placement of the drain allows equally efficient resorption of rinsage liquid and remaining subdural blood as long as the dura is not sealed during surgery. In contrast to the last-named authors, the choice of a two-burr-hole strategy allowed us to pass up active peri-operative draining methods. It also allowed us to stay away from hazardous enlargement of the burr-holes.
Good outcome results from low perioperative mortality and low postoperative morbidity. In the literature, mortality during hospitalization for SCSH reaches from 5 to 13.3 % (28, 29, 31 ). In the present study, the perioperative mortality was 3.4 % with fatal outcome in a total of 5 cases. Only 3 patients expired from direct surgical complications (two patients continued to bleed from subdural membranes despite trepanation, and one patient developed immediate post-operative epidural bleeding). Moreover, only 1 patient succumbed to pulmonary failure eventually in relation with our post-operative management strategy.
Regarding morbidity, few reliable data are available in the literature. In the present study, mean GOS showed good outcome (GOS 4 and 5) in 92.5% at 3 months follow-up. This result has to been considered in light of the patients' mean age of 71.5 years, and the high prevalence of comorbidities. It thus plainly illustrates how good functional outcome can be achieved by the presented strategy.
In the present series, the rate of documented hematoma persistence or recurrence was 13.1 %. Surgical re-intervention was limited to those 9.3 % who became clinically manifest.
In the literature, re-intervention rates after burr-hole surgery with subdural drains vary between 8.3 and 26.5 % (5, 6, 14, 19, 20, 24, 35) . Results from the present series, and 7.6 % obtained by the akin strategy reported by Gazzeri et al. (7), thus represent comparatively low incidences of recurrence. Moreover, classic procedures are followed in up to 8 % by tension pneumocephalus (16, 22, 30) . In the present series, as in the series reported by Gazzeri et al. The absence of foreign material in direct contact with intracranial structures thus possibly limits the propagation of infection agents into deep compartments, and thus potentially moderates the formation of deleterious secondary empyema. Even though it appears tempting and reasonable to lower the incidence of deep brain infection by choosing non-irritant surgical methods such as extracranial drains, large-scale studies will be necessary to fully elucidate this matter of importance as the available literature is limited in its statistically significance by a too low numbers of patients to demonstrate this effect.
Post-operative seizure in SCSH is reported to occur in 7 to 13.7 % (4, 13, 29). Kotwica et al. (13) suggested that the capsule of the hematoma might play an important role in its occurrence. In the present study, post-operative inaugural seizure was noted in 8.2 % of patients and 6.6 % of operated sides. This comparatively low incidence may corroborate the theory from Gazzeri et al. (7) stipulating that the absence of an irritating drain in direct contact with the hematoma capsule moderates the risk of seizure during the phase of brain reexpansion. In light of our experience, we recommend to limit antiepileptic prophylaxis to a single loading dose of Phenytoin before the end of surgery. This approach not only allowed us to obtain comparatively low incidence of early post-operative seizure, but also limited the occurrence of local or systemic side effects of commonly used anti-epileptic therapies.
Comparisons between series are limited so far as there is no clear consent in the literature regarding indication and modalities of perioperative anti-epileptic coverage (4, 13, 29) .
Prospective randomized trials will thus be necessary to determine if the absence of an irritating drain in contact with the hematoma capsule consistently reduces the incidence of post-operative seizure. Meanwhile, potentially lowering its incidence by the use of nonirritant surgical methods such as extracranial drains appears as a promising and reasonable approach.
Concerning safety, no complications related to traumatic handling of a subperiostal drain was reported in the present series. In our experience, the insertion of the drain under the periosteum is particularly trouble-free as no manipulation of intracranial structures is necessary. Moreover, patient-care is simplified as accidental traumatic removal of the drains bears very limited risk of subsequent intra-cranial hemorrhage. Regarding cost-effectiveness, active avoidance of complications should be associated with early discharge. Few data regarding patient orientation after burr-hole trepanation are available in the literature. In the present series, virtually half of all patients (48.3 %) were discharged without particular medical measures after a mean hospitalization time of 8.8 days.
Conclusions
Two-burr-holes trepanation in combination with a subperiostal non-aspiring draining system is an effective, safe, technically easy, and cost-efficient treatment strategy for SCSH.
Rates of complications are well within range of studies advocating other forms or treatment.
The most evident advantage of the method is its technical ease and safety. In contrast to other methods, this strategy passes up hazardous enlargement of burr-holes and stays away from delicate active draining systems. Patient safety is improved as traumatic handling of the drains does not bear the risk of either injuring subdural membranes leading to secondary bleeding, or harming brain parenchyma directly. As no foreign material comes into direct contact with intracranial structures, potential advantages include low incidence of deep infection and limitation of postoperative seizure. As statistical comparisons between series are limited so far due to variable perioperative medical seizure prevention and due to low numbers of infection, large-scale prospective randomized trials will be required to confirm these results. Meanwhile, potentially lowering the incidence of deep infections and early seizures by using a non-irritant surgical method appears most promising and reasonable. In the present study, cost-effectiveness was achieved through good functional outcome, low incidence of complications, and therefore short duration of hospitalization. 
